We've found
2,621
archived clinical trials in
Urology
We've found
2,621
archived clinical trials in
Urology
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Combined Spinal Epidural Urinary Retention
Updated: 12/31/1969
Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement?
Status: Enrolling
Updated: 12/31/1969
Combined Spinal Epidural Urinary Retention
Updated: 12/31/1969
Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Updated: 12/31/1969
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Updated: 12/31/1969
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
Updated: 12/31/1969
Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
Status: Enrolling
Updated: 12/31/1969
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
Updated: 12/31/1969
Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Updated: 12/31/1969
E-Moms: A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Status: Enrolling
Updated: 12/31/1969
A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Updated: 12/31/1969
E-Moms: A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Updated: 12/31/1969
Protocol for Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence An RCT: Hypnotherapy Or Pharmacotherapy
Status: Enrolling
Updated: 12/31/1969
Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Updated: 12/31/1969
Protocol for Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence An RCT: Hypnotherapy Or Pharmacotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials